Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components
Small Methods · 2026-01 · 10 (2)
DOI: 10.1002/smtd.202401632 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small Methods, online erschienen am 28.05.2025. Verfasst von Fan Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of RNA Innovation, Science and Engineering, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Ce…. Hauptthemen laut MEDLINE: Gene Editing, Nanoparticles, Lipids, CRISPR-Cas Systems. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 220 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Strategic Priority Research Program of the Chinese Academy of Science, National Natural Science Foundation of China, Shanghai Sci-Tech Inno Center for Infection & Immunity.
Abstract (Originalsprache)
Gene editing has emerged as a promising therapeutic option for treating genetic diseases. However, a central challenge in the field is the safe and efficient delivery of these large editing tools, especially in vivo. Lipid nanoparticles (LNPs) are attractive nonviral vectors due to their low immunogenicity and high delivery efficiency. To maximize editing efficiency, LNPs should efficiently protect gene editing components against multiple biological barriers and release them into the cytoplasm of target cells. In this review, the widely used CRISPR gene editing systems are first overviewed. Then, each component of LNPs, as well as their effects on delivery, are systematically discussed. Following this, the current LNP engineering strategies to achieve non‐liver targeting are summarized. Finally, preclinical and clinical applications of LNPs for in vivo genome editing are highlighted, and perspectives for the future development of LNPs are provided.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of RNA Innovation, Science and Engineering, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy…
- Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, 19104, USA.
ORCID-Profile: Michael J Mitchell, Xuexiang Han
Förderung
- Strategic Priority Research Program of the Chinese Academy of Science
- National Natural Science Foundation of China
- Shanghai Sci-Tech Inno Center for Infection & Immunity
Zitieren
APA
Wu, F., Li, N., Xiao, Y., Palanki, R., Yamagata, H., Mitchell, M. J., & Han, X. (2026). Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components. Small Methods, 10(2). https://doi.org/10.1002/smtd.202401632
Vancouver
Wu F, Li N, Xiao Y, Palanki R, Yamagata H, Mitchell MJ, et al. Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components. Small Methods. 2026;10(2). doi:10.1002/smtd.202401632
BibTeX
@article{Wu2026,
author = {Wu, Fan and Li, Nei and Xiao, Yudian and Palanki, Rohan and Yamagata, Hannah and Mitchell, Michael J and Han, Xuexiang},
title = {Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components},
journal = {Small Methods},
year = {2026},
volume = {10},
number = {2},
doi = {10.1002/smtd.202401632}
}
EUVIMED